HER-2 belongs to the human epidermal growth factor receptor (HER) family. Via different signal transduction pathways, HER-2 regulates normal cell proliferation, survival, and differentiation. Recently, it was reported that MCF10A, BT474, and MDA-MB-231 cells bearing the HER2 K753E mutation were resistant to lapatinib. Present study revealed that HER-2 mutant K753E showed some contrasting behaviour as compared to wild, L768S and V773L HER-2 in complex with lapatinib while similar to previously known lapatinib resistant L755S HER-2 mutant. Lapatinib showed stable but reverse orientation in binding site of K753E and the highest binding energy among studied HER2-lapatinib complexes but slightly lesser than L755S mutant. Results indicate that K7...
<div><p>The pressure exerted by drugs targeted to a protein in any therapy inevitably leads to the e...
Abstract Background Gastric cancer (GC) is one of the leading causes of cancer-related deaths worldw...
The pressure exerted by drugs targeted to a protein in any therapy inevitably leads to the emergence...
<p>(A) Backbone RMSD’s as a function of time for wild and mutant HER-2 in complex with lapatinib, (B...
<p>(A) MM/PBSA free energy calculation of HER-2 L755S-Lapatinib complex, (B) Free energy decompositi...
<p>Free energy landscape of HER-2 as a function of first two principal components PC1 and PC2 (A) wi...
<p>Free energy landscape of HER-2 as a function of first two principal components PC1 and PC2 (A) L7...
Purpose: Resistance to anti-HER2 therapies in HER2+ breast cancer can occur through activation of al...
[[abstract]]HER2 is a major proliferative driver in lung cancer and the role of HER2-targeting drugs...
Hormone receptor positive breast cancer accounts for approximately 60% of breast cancers, and endocr...
HER2-targeted therapies have greatly improved the outcome for patients with HER2-positive breast can...
HER2 overexpression has been implicated in breast cancer. Lapatinib is a dual EGFR/HER2 tyrosine kin...
HER2/Neu gene mutations have been identified in lung cancer. Expression of a HER2 mutant containing ...
Signaling through epidermal growth factor receptor (EGFR/ErbB) family members plays a very important...
The pressure exerted by drugs targeted to a protein in any therapy inevitably leads to the emergence...
<div><p>The pressure exerted by drugs targeted to a protein in any therapy inevitably leads to the e...
Abstract Background Gastric cancer (GC) is one of the leading causes of cancer-related deaths worldw...
The pressure exerted by drugs targeted to a protein in any therapy inevitably leads to the emergence...
<p>(A) Backbone RMSD’s as a function of time for wild and mutant HER-2 in complex with lapatinib, (B...
<p>(A) MM/PBSA free energy calculation of HER-2 L755S-Lapatinib complex, (B) Free energy decompositi...
<p>Free energy landscape of HER-2 as a function of first two principal components PC1 and PC2 (A) wi...
<p>Free energy landscape of HER-2 as a function of first two principal components PC1 and PC2 (A) L7...
Purpose: Resistance to anti-HER2 therapies in HER2+ breast cancer can occur through activation of al...
[[abstract]]HER2 is a major proliferative driver in lung cancer and the role of HER2-targeting drugs...
Hormone receptor positive breast cancer accounts for approximately 60% of breast cancers, and endocr...
HER2-targeted therapies have greatly improved the outcome for patients with HER2-positive breast can...
HER2 overexpression has been implicated in breast cancer. Lapatinib is a dual EGFR/HER2 tyrosine kin...
HER2/Neu gene mutations have been identified in lung cancer. Expression of a HER2 mutant containing ...
Signaling through epidermal growth factor receptor (EGFR/ErbB) family members plays a very important...
The pressure exerted by drugs targeted to a protein in any therapy inevitably leads to the emergence...
<div><p>The pressure exerted by drugs targeted to a protein in any therapy inevitably leads to the e...
Abstract Background Gastric cancer (GC) is one of the leading causes of cancer-related deaths worldw...
The pressure exerted by drugs targeted to a protein in any therapy inevitably leads to the emergence...